Analytical & Bioanalytical Method Validation
Global Harmonisation of Dissolution Method Validation Across US, EU and UK Sites Global Harmonisation of Dissolution Method Validation Across US, EU and UK Sites Understanding Dissolution Method Validation Dissolution method validation is a crucial component of pharmaceutical development and quality control processes. It ensures that the dissolution testing method accurately reflects the performance of a drug product in vivo. Regulatory…
Use of USP and EMA Guidance in Designing Dissolution Method Validation Protocols Use of USP and EMA Guidance in Designing Dissolution Method Validation Protocols In the realm of pharmaceutical manufacturing, ensuring the quality and efficacy of drug products is paramount. Dissolution testing plays a crucial role in this quality assurance process. With evolving regulatory expectations from the FDA, the EMA,…
Validating In Vitro Release Tests for Semi-Solid and Transdermal Products Validating In Vitro Release Tests for Semi-Solid and Transdermal Products The validation of in vitro release tests (IVRT) and in vitro permeation tests (IVPT) for semi-solid and transdermal products is a critical component in the pharmaceutical quality assurance framework. This article delineates the regulatory expectations outlined by various authoritative bodies,…
Inspection-Ready Dissolution Method Validation Reports for FDA and EMA Introduction to Dissolution Method Validation Dissolution method validation is a critical process in the pharmaceutical industry, ensuring that products meet regulatory expectations for quality and reproducibility. This guide provides an in-depth, step-by-step tutorial on creating inspection-ready dissolution validation reporting, which is crucial for submissions to regulatory authorities, including the FDA and…
Analytical Method Verification vs Full Validation When Receiving a Compendial Method In the pharmaceutical industry, the validation of analytical methods is a critical process that ensures the reliability and accuracy of testing when introducing new methodologies in the laboratory. Method verification and full validation, particularly in the context of pharmacopoeial methods, represent two distinct approaches guided by regulatory expectations, including…
Regulatory Expectations for Method Transfer Between Sponsor and CMO Sites In the landscape of pharmaceutical manufacturing, the transfer of analytical methods between Sponsor organizations and Contract Manufacturing Organizations (CMOs) is an essential practice. Compliance with regulatory expectations for such transfers stems from understanding the principles outlined in guidance documents from the US FDA, EMA, and PIC/S, among others. This article…
Protocol Design for Analytical Method Transfer – Comparative Testing and Criteria Protocol Design for Analytical Method Transfer – Comparative Testing and Criteria Transferring analytical methods between laboratory sites is a critical operation within the pharmaceutical industry to ensure accuracy and reliability in testing results. According to regulatory expectations established by authorities such as the FDA, EMA, and MHRA, a robust…
Analytical Method Transfer Strategies Between QC Laboratories Analytical Method Transfer Strategies Between QC Laboratories In the pharmaceutical industry, ensuring the quality and integrity of analytical methods across various laboratories is critical. This tutorial provides a detailed step-by-step guide on analytical method transfer strategies applicable to Quality Control (QC) laboratories, focusing on maintaining compliance with regulations set forth by governing bodies…
Re-Validation Triggers After Post-Approval Changes Impacting Analytical Methods In the pharmaceutical industry, validation is a critical process that ensures the integrity, consistency, and reliability of analytical methods used throughout the product lifecycle. Regulatory agencies, such as the US FDA and the EMA, mandate stringent guidelines for validation to ensure that the methods employed are robust, accurate, and reproducible. This article…
Documenting Analytical Method Transfer Reports for FDA, EMA and MHRA Documenting Analytical Method Transfer Reports for FDA, EMA and MHRA The transfer of analytical methods between laboratories is a critical component in the pharmaceutical and biotechnology industries. Regulatory agencies such as the FDA, EMA, and MHRA require thorough documentation to ensure compliance with current Good Manufacturing Practices (cGMP). This article…